185 related articles for article (PubMed ID: 22806358)
1. Paclitaxel delivery using carrier made from curcumin derivative: synergism between carrier and the loaded drug for effective cancer treatment.
Amornwachirabodee K; Chiablaem K; Wacharasindhu S; Lirdprapamongkol K; Svasti J; Vchirawongkwin V; Wanichwecharungruang SP
J Pharm Sci; 2012 Oct; 101(10):3779-86. PubMed ID: 22806358
[TBL] [Abstract][Full Text] [Related]
2. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
[TBL] [Abstract][Full Text] [Related]
3. Delivery of curcumin by directed self-assembled micelles enhances therapeutic treatment of non-small-cell lung cancer.
Zhu WT; Liu SY; Wu L; Xu HL; Wang J; Ni GX; Zeng QB
Int J Nanomedicine; 2017; 12():2621-2634. PubMed ID: 28435247
[TBL] [Abstract][Full Text] [Related]
4. Paclitaxel and curcumin coadministration in novel cationic PEGylated niosomal formulations exhibit enhanced synergistic antitumor efficacy.
Alemi A; Zavar Reza J; Haghiralsadat F; Zarei Jaliani H; Haghi Karamallah M; Hosseini SA; Haghi Karamallah S
J Nanobiotechnology; 2018 Mar; 16(1):28. PubMed ID: 29571289
[TBL] [Abstract][Full Text] [Related]
5. Curcumin loaded polymeric micelles inhibit breast tumor growth and spontaneous pulmonary metastasis.
Liu L; Sun L; Wu Q; Guo W; Li L; Chen Y; Li Y; Gong C; Qian Z; Wei Y
Int J Pharm; 2013 Feb; 443(1-2):175-82. PubMed ID: 23287774
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of a novel phytosome-loaded chitosan microsphere system for curcumin delivery.
Zhang J; Tang Q; Xu X; Li N
Int J Pharm; 2013 May; 448(1):168-74. PubMed ID: 23524117
[TBL] [Abstract][Full Text] [Related]
7. Starch-based microspheres for sustained-release of curcumin: preparation and cytotoxic effect on tumor cells.
Pereira AG; Fajardo AR; Nocchi S; Nakamura CV; Rubira AF; Muniz EC
Carbohydr Polym; 2013 Oct; 98(1):711-20. PubMed ID: 23987403
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide based oral nanocarriers for the improvement of bioavailability and anticancer efficacy of curcumin.
Chaurasia S; Patel RR; Chaubey P; Kumar N; Khan G; Mishra B
Carbohydr Polym; 2015 Oct; 130():9-17. PubMed ID: 26076595
[TBL] [Abstract][Full Text] [Related]
9. Formulation of curcumin delivery with functionalized single-walled carbon nanotubes: characteristics and anticancer effects in vitro.
Li H; Zhang N; Hao Y; Wang Y; Jia S; Zhang H; Zhang Y; Zhang Z
Drug Deliv; 2014 Aug; 21(5):379-87. PubMed ID: 24160816
[TBL] [Abstract][Full Text] [Related]
10. Cyclic hexapeptide-conjugated nanoparticles enhance curcumin delivery to glioma tumor cells and tissue.
Zhang X; Li X; Hua H; Wang A; Liu W; Li Y; Fu F; Shi Y; Sun K
Int J Nanomedicine; 2017; 12():5717-5732. PubMed ID: 28848349
[TBL] [Abstract][Full Text] [Related]
11. Arginine, glycine, aspartic acid peptide-modified paclitaxel and curcumin co-loaded liposome for the treatment of lung cancer: in vitro/vivo evaluation.
Jiang K; Shen M; Xu W
Int J Nanomedicine; 2018; 13():2561-2569. PubMed ID: 29731631
[TBL] [Abstract][Full Text] [Related]
12. Exceedingly Higher co-loading of Curcumin and Paclitaxel onto Polymer-functionalized Reduced Graphene Oxide for Highly Potent Synergistic Anticancer Treatment.
Muthoosamy K; Abubakar IB; Bai RG; Loh HS; Manickam S
Sci Rep; 2016 Sep; 6():32808. PubMed ID: 27597657
[TBL] [Abstract][Full Text] [Related]
13. Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors.
Jiang H; Geng D; Liu H; Li Z; Cao J
Drug Deliv; 2016 Nov; 23(9):3665-3673. PubMed ID: 27749102
[TBL] [Abstract][Full Text] [Related]
14. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement.
Li X; Yuan H; Zhang C; Chen W; Cheng W; Chen X; Ye X
J Pharm Pharmacol; 2016 Aug; 68(8):980-8. PubMed ID: 27283220
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel and di-fluorinated curcumin loaded in albumin nanoparticles for targeted synergistic combination therapy of ovarian and cervical cancers.
Gawde KA; Sau S; Tatiparti K; Kashaw SK; Mehrmohammadi M; Azmi AS; Iyer AK
Colloids Surf B Biointerfaces; 2018 Jul; 167():8-19. PubMed ID: 29625422
[TBL] [Abstract][Full Text] [Related]
16. Smart nanoplatform for sequential drug release and enhanced chemo-thermal effect of dual drug loaded gold nanorod vesicles for cancer therapy.
Zhu F; Tan G; Zhong Y; Jiang Y; Cai L; Yu Z; Liu S; Ren F
J Nanobiotechnology; 2019 Mar; 17(1):44. PubMed ID: 30917812
[TBL] [Abstract][Full Text] [Related]
17. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: current state-of-the-art.
Ahmad MZ; Alkahtani SA; Akhter S; Ahmad FJ; Ahmad J; Akhtar MS; Mohsin N; Abdel-Wahab BA
J Drug Target; 2016; 24(4):273-93. PubMed ID: 26066739
[TBL] [Abstract][Full Text] [Related]
18. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J
Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133
[TBL] [Abstract][Full Text] [Related]
19. Paclitaxel and its formulations.
Singla AK; Garg A; Aggarwal D
Int J Pharm; 2002 Mar; 235(1-2):179-92. PubMed ID: 11879753
[TBL] [Abstract][Full Text] [Related]
20. Facile preparation of pH-sensitive chitosan microspheres for delivery of curcumin; characterization, drug release kinetics and evaluation of anticancer activity.
Pooresmaeil M; Namazi H
Int J Biol Macromol; 2020 Nov; 162():501-511. PubMed ID: 32574741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
